vyndamax

Generic: tafamidis

Labeler: pfizer laboratories div pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vyndamax
Generic Name tafamidis
Labeler pfizer laboratories div pfizer inc
Dosage Form CAPSULE, LIQUID FILLED
Routes
ORAL
Active Ingredients

tafamidis 61 mg/1

Manufacturer
Pfizer Laboratories Div Pfizer Inc

Identifiers & Regulatory

Product NDC 0069-8730
Product ID 0069-8730_4ee63a96-9d81-4941-a641-510beb6abb81
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA212161
Listing Expiration 2027-12-31
Marketing Start 2019-08-27

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00698730
Hyphenated Format 0069-8730

Supplemental Identifiers

RxCUI
2168534 2168540 2168542 2168548
UNII
ZU7CF08A1A 8FG9H9D31J

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vyndamax (source: ndc)
Generic Name tafamidis (source: ndc)
Application Number NDA212161 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 61 mg/1
source: ndc
Packaging
  • 30 BLISTER PACK in 1 CARTON (0069-8730-30) / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0069-8730-01)
source: ndc

Packages (1)

Ingredients (1)

tafamidis (61 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4ee63a96-9d81-4941-a641-510beb6abb81", "openfda": {"unii": ["ZU7CF08A1A", "8FG9H9D31J"], "rxcui": ["2168534", "2168540", "2168542", "2168548"], "spl_set_id": ["1b4121ee-a733-4456-a917-be2603477839"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (0069-8730-30)  / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0069-8730-01)", "package_ndc": "0069-8730-30", "marketing_start_date": "20190827"}], "brand_name": "Vyndamax", "product_id": "0069-8730_4ee63a96-9d81-4941-a641-510beb6abb81", "dosage_form": "CAPSULE, LIQUID FILLED", "product_ndc": "0069-8730", "generic_name": "tafamidis", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vyndamax", "active_ingredients": [{"name": "TAFAMIDIS", "strength": "61 mg/1"}], "application_number": "NDA212161", "marketing_category": "NDA", "marketing_start_date": "20190827", "listing_expiration_date": "20271231"}